Free Republic 4th Quarter Fundraising Target: $88,000 Receipts & Pledges to-date: $7,804
Woo hoo!! And the first 8% is in!! Thank you all very much!!

Keyword: cancerdrug

Brevity: Headers | « Text »
  • New wonder drug matches and kills all kinds of cancer — human testing starts 2014

    07/11/2013 11:38:50 AM PDT · by GrandJediMasterYoda · 93 replies
    Ny Post ^ | 7/11/13 | By MICHAEL BLAUSTEIN
    New wonder drug matches and kills all kinds of cancer — human testing starts 2014 By MICHAEL BLAUSTEIN Last Updated: 2:03 PM, July 11, 2013 Posted: 12:55 PM, July 11, 2013 Stanford researchers are on track to begin human trials of a potentially potent new weapon against cancer, and would-be participants are flooding in following the Post’s initial report on the discovery. The progress comes just two months after the groundbreaking study by Dr Irv Weissman, who developed an antibody that breaks down a cancer's defense mechanisms in the body. A protein called CD47 tells the body not to "eat"...
  • FDA Approves Genentech’s Kadcyla (Ado-Trastuzumab Emtansine), the First Antibody-Drug Conjugate...

    02/25/2013 12:45:13 PM PST · by neverdem · 10 replies
    Business Wire via IBD ^ | 02/22/2013 | NA
    FDA Approves Genentech’s Kadcyla (Ado-Trastuzumab Emtansine), the First Antibody-Drug Conjugate for Treating HER2-Positive Metastatic Breast Cancer New Personalized Medicine Helped People in Phase III Study Live Longer, Compared to Standard Treatment -- SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has approved Kadcyla™(ado-trastuzumab emtansine or T-DM1) for the treatment of people with HER2-positive metastatic breast cancer (mBC) who have received prior treatment with Herceptin® (trastuzumab) and a taxane chemotherapy. Kadcyla is the fourth medicine from Genentech to receive FDA approval for...
  • Experts fear shortage of “unprofitable” cancer drug

    11/18/2012 3:43:27 PM PST · by Olog-hai · 3 replies ^ | 18 Nov 12 14:40 CET | (The Local/jcw)
    German cancer experts are warning of a looming shortage of one of the most widely used drugs to treat the disease—because pharmaceutical companies say it is not financially worth their while to make it any more. Fluorouracil, also known as 5-FU, is a chemotherapy agent used to treat bowel and breast cancer. It is one of the most commonly prescribed drugs for cancer patients worldwide. But many of Germany’s top providers have stopped making the drug because it is not as profitable as other, more expensive ones. Of the six main companies which supplied 5-FU to pharmacies across the country,...
  • Cancer drug reverses Alzheimer's in mice: study

    02/09/2012 1:00:57 PM PST · by Mount Athos · 57 replies
    afp ^ | 09 February 2012
    A widely available cancer drug has shown remarkable success in reversing Alzheimer's disease in mice, raising hope of a breakthrough against incurable dementia in humans, US researchers said Thursday. Mice treated with the drug, known as bexarotene, became rapidly smarter and the plaque in their brains that was causing their Alzheimer's started to disappear within hours, said the research in the journal Science. "We were shocked and amazed," lead author Gary Landreth of the Department of Neurosciences at Case Western Reserve University School of Medicine in Ohio told AFP. "Things like this had never, ever been seen before," he said....
  • Diabetes drug shows promise in reducing risk of cancer (metformin)

    11/24/2011 4:52:38 PM PST · by decimon · 8 replies
    Michigan State University ^ | November 23, 2011
    Metformin prevents tumors from growing in human culturesEAST LANSING, Mich. — An inexpensive drug that treats Type-2 diabetes has been shown to prevent a number of natural and man-made chemicals from stimulating the growth of breast cancer cells, according to a newly published study by a Michigan State University researcher. The research, led by pediatrics professor James Trosko and colleagues from South Korea's Seoul National University, provides biological evidence for previously reported epidemiological surveys that long-term use of the drug metformin for Type-2 diabetes reduces the risk of diabetes-associated cancers, such as breast cancers. The research appears in the current...
  • Cheap, safe drug kills most cancers

    01/17/2007 5:28:53 PM PST · by LibWhacker · 65 replies · 2,526+ views
    New Scientist ^ | 1/17/06 | Andy Coghlan
    It sounds almost too good to be true: a cheap and simple drug that kills almost all cancers by switching off their “immortality”. The drug, dichloroacetate (DCA), has already been used for years to treat rare metabolic disorders and so is known to be relatively safe. It also has no patent, meaning it could be manufactured for a fraction of the cost of newly developed drugs. Evangelos Michelakis of the University of Alberta in Edmonton, Canada, and his colleagues tested DCA on human cells cultured outside the body and found that it killed lung, breast and brain cancer cells, but...